Ticker
ABCLCompany Name
ABCELLERA BIOLOGICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 1.4B | $ 137.18M | 9.78% |
3/31/2025 | $ 1.34B | $ 63.21M | 4.7% |
12/31/2024 | $ 1.36B | $ 60.74M | 4.46% |
9/30/2024 | $ 1.39B | $ 66.27M | 4.76% |
6/30/2024 | $ 1.41B | $ 66.45M | 4.7% |
3/31/2024 | $ 1.46B | $ 68.08M | 4.65% |
12/31/2023 | $ 1.49B | $ 71.22M | 4.79% |
9/30/2023 | $ 1.51B | $ 75.19M | 4.97% |
6/30/2023 | $ 1.54B | $ 78.08M | 5.08% |
3/31/2023 | $ 1.5B | $ 77.27M | 5.16% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for ABCELLERA BIOLOGICS INC is calculated as follows: Debt [ $ 6.08M ] / Assets [ $ 23.49M ]
(=) Debt to Assets [ 25.91% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2019
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |